Correlation Between Mineralys Therapeutics, and Solid Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Solid Biosciences LLC, you can compare the effects of market volatilities on Mineralys Therapeutics, and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Solid Biosciences.

Diversification Opportunities for Mineralys Therapeutics, and Solid Biosciences

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mineralys and Solid is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Solid Biosciences go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Solid Biosciences

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Solid Biosciences. In addition to that, Mineralys Therapeutics, is 1.22 times more volatile than Solid Biosciences LLC. It trades about -0.05 of its total potential returns per unit of risk. Solid Biosciences LLC is currently generating about 0.03 per unit of volatility. If you would invest  583.00  in Solid Biosciences LLC on August 28, 2024 and sell it today you would earn a total of  3.00  from holding Solid Biosciences LLC or generate 0.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Solid Biosciences LLC

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Solid Biosciences LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Solid Biosciences LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Mineralys Therapeutics, and Solid Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and Solid Biosciences

The main advantage of trading using opposite Mineralys Therapeutics, and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.
The idea behind Mineralys Therapeutics, Common and Solid Biosciences LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity